Total Payments
$3,892
2024 Payments
$798.51
Companies
37
Transactions
258
Medicare Patients
766
Medicare Billing
$59,213
Payment Breakdown by Category
Food & Beverage$3,767 (96.8%)
Education$125.15 (3.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,767 | 250 | 96.8% |
| Education | $125.15 | 8 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $950.26 | 71 | $0 (2024) |
| Amgen Inc. | $368.97 | 18 | $0 (2024) |
| PFIZER INC. | $231.00 | 14 | $0 (2024) |
| TherapeuticsMD, Inc. | $216.59 | 10 | $0 (2021) |
| Exeltis, USA Inc. | $211.00 | 13 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $206.43 | 25 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $168.41 | 10 | $0 (2024) |
| Evofem Biosciences, Inc. | $161.23 | 10 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $152.17 | 6 | $0 (2024) |
| Lupin Inc. | $151.21 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $798.51 | 42 | Amgen Inc. ($141.90) |
| 2023 | $687.07 | 55 | AbbVie Inc. ($221.69) |
| 2022 | $404.46 | 28 | ABBVIE INC. ($145.90) |
| 2021 | $431.20 | 29 | AbbVie Inc. ($134.97) |
| 2020 | $242.72 | 17 | AbbVie Inc. ($78.93) |
| 2019 | $726.75 | 46 | AbbVie, Inc. ($199.39) |
| 2018 | $335.73 | 25 | AbbVie, Inc. ($119.84) |
| 2017 | $265.50 | 16 | AMAG Pharmaceuticals, Inc. ($55.98) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, MYFEMBREE | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: WOMENS HEALTH | ||||||
| 12/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.46 | General |
| 12/02/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Urology | ||||||
| 11/26/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.31 | General |
| 11/14/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $38.03 | General |
| Category: Hematology | ||||||
| 11/11/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: HORMONE THERAPY | ||||||
| 10/23/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $4.14 | General |
| 10/10/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: WOMENS HEALTH | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: VACCINE | ||||||
| 09/16/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: WOMENS HEALTH | ||||||
| 09/13/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $4.19 | General |
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Biological | ||||||
| 08/29/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $49.32 | General |
| Category: Hematology | ||||||
| 08/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Bone Health | ||||||
| 08/13/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $5.61 | General |
| 08/12/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: WOMENS HEALTH | ||||||
| 08/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: HORMONE THERAPY | ||||||
| 07/22/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: WOMENS HEALTH | ||||||
| 07/19/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.94 | General |
| 07/02/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: WOMENS HEALTH | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Biological | ||||||
| 06/11/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: VACCINES | ||||||
| 06/05/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 119 | 124 | $14,346 | $6,347 |
| 2022 | 5 | 211 | 227 | $23,710 | $11,708 |
| 2021 | 5 | 247 | 1,447 | $69,975 | $31,356 |
| 2020 | 5 | 189 | 200 | $20,025 | $9,802 |
Total Patients
766
Total Services
1,998
Medicare Billing
$59,213
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 32 | $6,400 | $2,283 | 35.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 54 | 54 | $4,320 | $2,276 | 52.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 38 | 38 | $3,626 | $1,787 | 49.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 87 | 87 | $6,960 | $3,750 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 48 | $7,300 | $3,265 | 44.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 56 | 56 | $4,760 | $2,684 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $3,740 | $1,782 | 47.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 19 | $950.00 | $227.37 | 23.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 15 | 1,200 | $48,000 | $19,590 | 40.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 101 | 101 | $8,080 | $4,445 | 55.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 77 | 77 | $6,545 | $3,795 | 58.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 39 | $5,850 | $3,171 | 54.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 30 | $1,500 | $355.32 | 23.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 78 | 78 | $6,240 | $3,472 | 55.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 59 | 59 | $5,015 | $2,858 | 57.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 33 | $4,890 | $1,950 | 39.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $3,080 | $1,321 | 42.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 16 | $800.00 | $200.81 | 25.1% |
About Kenneth Chen, D. O
Kenneth Chen, D. O is a Obstetrics & Gynecology healthcare provider based in Willingboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902883010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kenneth Chen, D. O has received a total of $3,892 in payments from pharmaceutical and medical device companies, with $798.51 received in 2024. These payments were reported across 258 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($3,767).
As a Medicare-enrolled provider, Chen has provided services to 766 Medicare beneficiaries, totaling 1,998 services with total Medicare billing of $59,213. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Willingboro, NJ
- Active Since 12/29/2005
- Last Updated 03/17/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1902883010
Products in Payments
- LO LOESTRIN FE (Drug) $372.24
- Orilissa (Drug) $264.60
- EVENITY (Biological) $253.58
- MYFEMBREE (Drug) $211.60
- PREMARIN (Drug) $194.51
- BIJUVA (Drug) $176.81
- ACCRUFER (Drug) $152.17
- SOLOSEC (Drug) $151.21
- Phexxi (Drug) $121.79
- Prolia (Biological) $115.39
- ORILISSA (Drug) $111.32
- LILETTA (Drug) $107.57
- ORIAHNN (Drug) $94.29
- Vitafol Ultra (Drug) $89.59
- Xulane (Drug) $72.72
- SLYND (Drug) $68.60
- Veozah (Drug) $58.98
- Twirla (Drug) $58.48
- APTIMA (Device) $55.51
- MYOSURE TISSUE REMOVAL DEVICE (Device) $54.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Willingboro
David Hulbert, M.d, M.D
Obstetrics & Gynecology — Payments: $2,837
Obstetrics & Gynecology $2,837
Dr. Michael Snyder, M.d, M.D
Obstetrics & Gynecology — Payments: $1,946
Obstetrics & Gynecology $1,946
Dr. Ashley Hammer, M.d, M.D
Obstetrics & Gynecology — Payments: $1,928
Obstetrics & Gynecology $1,928
Michael Zalkin, M.d, M.D
Obstetrics & Gynecology — Payments: $1,926
Obstetrics & Gynecology $1,926
Francine Siegel, M.d, M.D
Obstetrics & Gynecology — Payments: $1,259
Obstetrics & Gynecology $1,259
Misa Belazi, Md, MD
Obstetrics & Gynecology — Payments: $1,248
Obstetrics & Gynecology $1,248